Additionally, 36.8% showed improvements in liver fibrosis, versus 22.4% in the placebo group. Participants also experienced improved liver enzyme levels and an average weight loss of 10.5%.

Ozempic can cause loss of body weight that isn’t fat, raising concerns that the drug lowers muscle mass and strength. New ...

A new study in mice has found that muscle loss associated with weight loss from GLP-1 medications like Ozempic may not be as ...

Muscle and strength loss in human aging, also known as sarcopenia, can result in trouble with balance and walking, according ...

Eli Lilly and Novo Nordisk are actively exploring other medical uses for their GLP-1 drugs, and have already seen some ...

Ozempic’s weight loss benefits might come at the cost of muscle strength, even if muscle size remains relatively stable. This ...

(Reuters) - Eli Lilly's blockbuster diabetes drug Mounjaro and weight-loss therapy Zepbound, as well as Novo Nordisk's rival medicines Ozempic and Wegovy are being studied to see whether they can ...